Peptide CDMOs in Europe

Contract Development and Manufacturing Organizations (CDMOs) specializing in peptide synthesis from clinical batches to commercial-scale production. Ideal for pharmaceutical and biotech enterprises requiring GMP-compliant facilities and regulatory support. CDMOs typically hold FDA and EMA inspected facilities covering solid-phase synthesis, purification, lyophilization, and analytical method development. Major peptide CDMOs serve both innovator drug developers and generic API customers across metabolic disease, oncology, and endocrinology therapeutic areas. Bachem, PolyPeptide, Lonza, CordenPharma, and WuXi AppTec represent the largest global CDMO capacity for peptide active pharmaceutical ingredients. Showing 27 suppliers listed in Europe.

Browse Peptide CDMOs operating in Europe serving pharmaceutical, biotech, and research customers. These suppliers offer Europe-based manufacturing, distribution, and quality control for peptide products including PolyPeptide Group, Almac Group, Evonik Health Care - Hanau and other vetted providers. Sourcing from Europe-based peptide cdmos provides advantages in regulatory compliance, shipping timelines, and supply chain transparency for buyers in this region.